Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAP-2: Metformin and Platelet Function in Prediabetes
NCT02682121Phase 1Completed
- Sponsor
- University of Utah
- Start
- Apr 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in prediabetes comparing Metformin with Placebo (2 arms). Primary endpoint: Gene expression levels of mitofusin 2 and uncoupling protein 2 at 6 months. Started Apr 2012; status: completed.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT02682121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682121.